Back to search

France· FR:64181296

VYJUVEK 5 x 1 000 000 000 unités formant plages /mL, de suspension et gel pour gel

A beremagene geperpavec product containing bérémagène géperpavec, registered in France by KRYSTAL BIOTECH NETHERLANDS (PAYS-BAS). The same ATC class is registered in 9 of our 19 countries.

ATC D03AX16

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVYJUVEK 5 x 1 000 000 000 unités form…ATCD03AX16REGISTER NO.FR:64181296PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Beremagene geperpavec is registered in 9 of 19 countries.

Countries holding a registration under ATC D03AX16 (beremagene geperpavec), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 6 of them publish a price we can compare per daily dose

Beremagene geperpavec · ATC D03AX16

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
BÉRÉMAGÈNE GÉPERPAVEC
Manufacturer
KRYSTAL BIOTECH NETHERLANDS (PAYS-BAS)
Country
France (FR)
ATC code
D03AX16
ATC class
Beremagene geperpavec
Defined daily dose
0.14286 ml, T
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955108139
    1 flacon copolymère de cyclooléfines (COC) de 1 ml - 1 flacon en verre de 1,5 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4c14721e-570c-410e-9a16-d65a43859376
GET /v1/drugs/4c14721e-570c-410e-9a16-d65a43859376?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64181296",
  "date_amm": "2025-04-23",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/25/1918",
  "substance": "BÉRÉMAGÈNE GÉPERPAVEC",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "suspension et  gel pour gel",
  "voies_administration": "cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

See everything about beremagene geperpavec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.